Journal of Hematology Oncology Pharmacy

Featured Articles

Safety of Inactivated Vaccines in Patients Receiving Immune Checkpoint Inhibitors

Austin Kurkowski, PharmD, BCOP, Grace A. Martin, PharmD, BCOP, Shelbie Ralph, PharmD, BCOP, Zahra Mahmoudjafari, PharmD, BCOP, Dennis Grauer, PhD, MS, Elizabeth Wulff-Burchfield, MD

Myeloablative and Reduced-Intensity Preparative Regimens for Allogeneic Transplant in the Outpatient versus Inpatient Setting in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes

Gretchen Pardo, PharmD, Beth Eddy, PharmD, BCOP, Zahra Mahmoudjafari, PharmD, BCOP, Dennis Grauer, PhD, MS, Joseph McGuirk, DO

Management of Acyclovir-Resistant Herpes Simplex Virus Infection in Patients Undergoing Hematopoietic Stem-Cell Transplantation

Jiyeon Joy Park, PharmD, BCOP, Esther Huang, PharmD, BCPS, BCOP, Colleen Ciccosanti, DO, MPH

Acute-Onset Congestive Heart Failure After 5-Fluorouracil Administration in a Patient with Colon Cancer

Vincent J. Cascone, PharmD, BCOP

Comparing Cyclophosphamide-Based versus Etoposide-Based Chemomobilization for Autologous Hematopoietic-Cell Transplant in Patients with Lymphoma

Taylor Dennison, PharmD, Zachary Pedretti, PharmD, Jing Zhu, PharmD, Kurtis Stocker, PharmD, Ryan Shaw, PharmD, Tatjana Grgic, PharmD, Maurice Alexander, PharmD, Marcie Riches, MD, MS, Hillary Heiling, BS, Jonathan Ptachcinski, PharmD

From the Literature

Daily Aspirin Does Not Lower Colorectal Cancer Risk When Started After Age 70

Adjuvant Nivolumab Therapy Prolongs Disease-Free Survival in Patients with Esophageal Cancer

New Data Reveal Mismatched Need and Supply of Oncology Physicians and Pharmacists in America

Oral Azacitidine Prolongs Survival in Patients with Acute Myeloid Leukemia

Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA

Enfortumab Vedotin Superior to Chemotherapy in Urothelial Cancer

Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA

Low-Dose Capecitabine Maintenance Therapy Improves Survival in Patients with Triple-Negative Breast Cancer

Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA

FDA Updates

Rylaze FDA Approved as Part of a Treatment Regimen for Pediatric Leukemia and Lymphoma

FDA Approved Truseltiq for Metastatic Cholangiocarcinoma with the FGFR2 Biomarker

FDA Approves Darzalex Faspro plus Pomalyst and Dexamethasone for Multiple Myeloma

FDA Approves Avapritinib for Advanced Systemic Mastocytosis

Pembrolizumab plus Lenvatinib Combination Receives Regular Approval for Advanced Endometrial Carcinoma

Padcev Receives Regular FDA Approval for Locally Advanced or Metastatic Urothelial Cancer

Meeting Highlights

Atezolizumab, Vemurafenib, and Cobimetinib Triplet Therapy Improves PFS in BRAF-Positive Melanoma

Two Ways to Target Tumors with KRAS Mutations

Targeted Therapy with Olaparib Beneficial in Metastatic Prostate Cancer with Gene Mutations

Ceritinib Effective in Treating Brain Metastases in NSCLC

Paradigm Shift: PARP Inhibitors Should Be Offered to All Patients with Ovarian Cancer

Adding CDK4/6 Inhibitor to Endocrine Therapy Improves Survival in Advanced Breast Cancer: New Standard of Care

Copyright © Green Hill Healthcare Communications, LLC. All rights reserved.